Selvita to invest in second lab and launch office in San Francisco

WSE-listed biotechnology firm Selvita is going to launch its second laboratory in Poland still this year and is considering opening its subsidiary's second office in the United States, the ISBnews reported citing Bogusław Sieczkowski, the deputy CEO at the firm. "We have been in talks [regarding building the laboratory] in three locations. We will employ 15-20 people in the first stage," Sieczkowski told the agency. The employment will increase in line with the firm's needs, he added. When it comes to the new office in the US, Selvita will probably decide to launch it in San Francisco.